Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.85
+0.26 (4.65%)
Aug 13, 2025, 4:00 PM - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $276.32 million as of August 14, 2025. Its market cap has decreased by -71.76% in one year.
Market Cap
276.32M
Enterprise Value
162.16M
1-Year Change
-71.76%
Ranking
Category
Stock Price
$5.85
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $276.32M, a decrease of -48.68%. That is a compound annual growth rate of -12.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 264.04M | -18.72% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 579.50B |
| Johnson & Johnson | 418.57B |
| AbbVie | 349.46B |
| UnitedHealth Group | 233.04B |
| Abbott Laboratories | 230.02B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |